$TPST Balance Sheet | Understand Stock

$TPST

$0.51 -$0.00 (0.16%) Close

$TPST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Insurance recovery of legal settlement
Prepaid expenses and other current assets
Total current assets

Property and equipment-net
Operating lease right-of-use assets
Other noncurrent assets
Total assets
Liabilities and Equity
Liabilities
Current liabilities:
Accounts payable
Accrued legal settlement
Accrued expenses
Current loan payable
Current loan payable (net of discount and issuance costs of $38 and $74, respectively)
Current operating lease liabilities
Accrued compensation
Interest payable
Early option exercise liability
Total current liabilities

Loan payable (net of discount and issuance costs of nil and $164, respectively)
Operating lease liabilities, less current portion
Total liabilities
Convertible preferred stock, $0.001 par value; shares 5,000,000 and 135,936,731 shares authorized at December 31, 2021 and 2020; nil and 114,686,731 shares issued and outstanding at December 31, 2021 and 2020, respectively; liquidation preference of $0 and $100,186,732 at December 31, 2021 and 2020, respectively
Stockholders' equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 15,979,404 and 4,927,161 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity

Total liabilities and stockholders’ equity

Comments